Microglia, the brain’s resident immune cells, play a key role in maintaining brain health, but they can also contribute to brain diseases under certain conditions [1].
Microglia are essential for clearing dead cells, responding to injuries and protecting neurons from infections. However, when these cells become overactive, they can shift from being protective to harmful, potentially leading to neurodegenerative diseases like Alzheimer’s or Parkinson’s.
Microglia are the brain’s first line of defense, identifying and eliminating threats like bacteria or viruses [2]. They also help prune unnecessary synapses during development, vital for maintaining neural circuitry.
This protective role is central to keeping the brain balanced, especially as it ages. However, when microglia remain in a prolonged activated state, they release pro-inflammatory chemicals due to infections or injuries.
These chemicals can cause inflammation and damage neurons, worsening neurological conditions.
Recent research highlights that overactive microglia can lead to the breakdown of the blood-brain barrier, which is crucial for preventing harmful substances from entering the brain [3].
A weakened blood-brain barrier allows toxins and pathogens to infiltrate, which can further worsen brain inflammation. In diseases like Alzheimer’s, these dysfunctions of microglia and the blood-brain barrier often coincide, contributing to cognitive decline.
While microglia are necessary for brain health, the challenge lies in regulating their activity. Therapeutic strategies aimed at controlling microglial overactivation could help prevent or slow down the progression of neurodegenerative diseases.
Ongoing studies explore potential treatments that could modulate microglial functions, aiming to reduce their harmful impact without compromising their protective roles.
This research, published in the International Journal of Molecular Sciences, sheds light on microglia’s beneficial and detrimental effects, particularly in the context of aging and neurodegenerative diseases.
[1] Frontiers in Immunology. Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function
[2] Journal of Neuroimmune Pharmacology. Microglia in Infectious Diseases of the Central Nervous System
[3] International Journal of Molecular Sciences. The Influence of Microglia on Neuroplasticity and Long-Term Cognitive Sequelae in Long COVID: Impacts on Brain Development and Beyond
